• Exchange: NASDAQ GM
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Immunomedics Inc

+ Add to Watchlist

IMMU:US

3.9600 USD 0.0300 0.75%

As of 20:10:00 ET on 04/17/2014.

Snapshot for Immunomedics Inc (IMMU)

Open: 3.9700 Day's Range: 3.8600 - 4.0750 Volume: 387,384
Previous Close: 3.9900 52wk Range: 2.4000 - 7.3500 1-Yr Rtn: +60.32%

Stock Chart for IMMU

No chart data available.
  • IMMU:US 3.9600
  • 1D
  • 1M
  • 1Y
3.9900
Interactive IMMU Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for IMMU

Current P/E Ratio (ttm) -
Estimated P/E(06/2014) -
Relative P/E vs. SPX -
Earnings Per Share (USD) (ttm) -0.2735
Est. EPS (USD) (06/2014) -0.3770
Est. PEG Ratio -
Market Cap (M USD) 329.86
Shares Outstanding (M) 83.30
30 Day Average Volume 760,351
Price/Book (mrq) 11.5117
Price/Sale (ttm) 33.1642
Dividend Indicated Gross Yield -%
Cash Dividend (USD) 0.0010
Dividend Ex-Date 03/15/2002
5 Year Dividend Growth -
Next Earnings Announcement 05/08/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for IMMU

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for IMMU

Immunomedics, Inc. develops, manufactures, and sells diagnostic imaging and therapeutic products. The Company's products are used to detect and treat cancer and infectious diseases. Immunomedics markets its products in the United States and Europe.

David M GoldenbergChairman/Chief Scientific OfcrCynthia L SullivanPresident/CEO
Peter P PfreundschuhVP:Finance/CFOChau ChengSenior Dir:Investor Relations
More Company Profile & Key Executives for IMMU

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil